179
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Investigation of CD24 and Its Expression in Iranian Relapsing-Remitting Multiple Sclerosis

, , , &
Pages 684-690 | Received 23 May 2011, Published online: 12 Sep 2011

REFERENCES

  • Agrawal, S. M., & Yong, V. W. (2007). Immunopathogenesis of multiple sclerosis. International Review of Neurobiology, 79, 99–126.
  • Alcina, A., Fedetz, M., Ndagire, D., Fernandez, O., Leyva, L., Guerrero, M., (2009). IL2RA/CD25 gene polymorphisms: Uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D). PLoS ONE, 4, e4137.
  • Bai, X. F., Li, O., Zhou, Q., Zhang, H., Joshi, P. S., Zheng, X., (2004). CD24 controls expansion and persistence of autoreactive T cells in the central nervous system during experimental autoimmune encephalomyelitis. Journal of Experimental Medicine, 200, 447–458.
  • Dean, G. (1994). How many people in the world have multiple sclerosis? Neuroepidemiology, 13, 1–7.
  • De Bruijn, M. L., Peterson, P. A., & Jackson, M. R. (1996). Induction of heat-stable antigen expression by phagocytosis is involved in in vitro activation of unprimed CTL by macrophages. Journal of Immunology, 156, 2686–2692.
  • Ebers, G. C., Sadovnick, A. D., & Risch, N. J. (1995). A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature, 377, 150–151.
  • Fogdell, A., Hillert, J., Sachs, C., & Olerup, O. (1995). The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5_0101 allele. Tissue Antigens, 46, 333–336.
  • Goris, A., Maranian, M., Walton, A., Yeo, T. W., Ban, M., Gray, J., (2006). CD24 Ala/Val polymorphism and multiple sclerosis. Journal of Neuroimmunology, 175, 200–202.
  • Haines, J. L., Ter-Minassian, M., Bazyk, A., Gusella, J. F., Kim, D. J., Terwedow, H., (1996). A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nature Genetics, 13(4), 469–471.
  • Hernández-Campo, P. M., Almeida, J., Matarraz, S., de Santiago, M., Sánchez, M. L., & Orfao, A. (2007). Quantitative analysis of the expression of glycosylphosphatidylinositol-anchored proteins during the maturation of different hematopoietic cell compartments of normal bone marrow. Cytometry Part B: Clinical Cytometry, 72, 34–42.
  • Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33, 1444–1452.
  • Liu, J. Q., Carl, J. W., Joshi, P. S., RayChaudhury, A., Pu, X. A., Shi, F. D., (2007). CD24 on the resident cells of the central nervous system enhances experimental autoimmune encephalomyelitis. Journal of Immunology, 178, 6227– 6235.
  • Liu, Y., Jones, B., Aruffo, A., Sullivan, K. M., Linsley, P. S., & Janeway, C. A., Jr. (1992). Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. Journal of Experimental Medicine, 175, 437–445.
  • Liu, Y., & Zheng, P. (2007). CD24: A genetic checkpoint in T cell homeostasis and autoimmune diseases. Trends in Immunology, 28, 315–320.
  • Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods, 25, 402–408.
  • McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. P., Lublin, F. D., (2001). Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology, l50, 121–127.
  • McElroy, J. P., & Oksenberg, J. R. (2008). Multiple sclerosis genetics. Current Topics in Microbiology and Immunology, 318, 45–72.
  • Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215–1218.
  • Noseworthy, J. H., Gold, R., & Hartung, H. P. (1999). Treatment of multiple sclerosis: Recent trials and future perspectives. Current Opinion in Neurology, 12, 279–293.
  • Oksenberg, J. R., Bernini, S. E., Barcellos, L. F., & Hauser, S. L. (2001). Multiple sclerosis: Genomic rewards. Journal of Neuroimmunology, 113, 171–184.
  • Otaegui, D., Saenz, A., Camano, P., Blazquez, L., Goicoechea, M., Ruiz- Martinez, J., (2006). CD24 V/V is an allele associated with the risk of developing multiple sclerosis in the Spanish population. Multiple Sclerosis, 12, 511–514.
  • Ramagopalan, S. V., Anderson, C., Sadovnick, A. D., & Ebers, G. C. (2007). Genomewide study of multiple sclerosis. New England Journal of Medicine, 357, 2199–2200.
  • Robertson, N. P., O'Riordan, J. I., Chataway, J., Kingsley, D. P. E., Miller, D. H., Clayton, D., et al. (1997). Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis. Lancet, 349, 1587–1590.
  • Ronaghi, M., Vallian, S., & Etemadifar, M. (2009). CD24 gene polymorphism is associated with the disease progression and susceptibility to multiple sclerosis in the Iranian population. Psychiatry Research, 170(2–3), 271–272.
  • Roxburgh, R. H., Seaman, S. R., Masterman, T., Hensiek, A. E., Sawcer, S. J., Vukusic, S., (2005). Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity. Neurology, 64, 1144–1151.
  • Sadovnick, A. D., Ebers, G. C., Dyment, D. A., & Risch, N. J. (1996). Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet, 347, 1728–1730.
  • Shahbazi, M., Ebadi, H., Fathi, D., Roshandel, D., Mahamadhoseeni, M., Rashidbaghan, A., (2009). CCR5-delta 32 allele is associated with the risk of developing multiple sclerosis in the Iranian population. Cellular and Molecular Neurobiology, 29(8), 1205–1209.
  • Shahbazi, M., Roshandel, D., Ebadi, H., Fathi, D., Zamani, M., Boghaee, M., (2010). High frequency of the IL-2-330 T/HLA-DRB1*1501 haplotype in patients with multiple sclerosis. Clinical Immunology, 137, 134–138.
  • Tabor, H. K., Risch, N. J., & Myers, R. M. (2002). Candidate-gene approaches for studying complex genetic traits: Practical considerations. Nature Reviews Genetics, 3, 391–397.
  • Wang, L., Lin, S., Rammohan, K. W., Liu, Z., Liu, J. Q., Liu, R. H., (2007). A dinucleotide deletion in CD24 confers protection against autoimmune diseases. PLoS Genetic, 6, 508–517.
  • Zamani, M., Gu, X. X., Spaepen, M., Vandevyver, C., Raus, J., Marynen, P., (1995). Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DRB1 chain in multiple sclerosis. Journal of Neuroimmonology, 59, 77–82.
  • Zhou, Q., Rammohan, K., Lin, S., Robinson, N., Li, O., Liu, X., et al. (2003). CD24 is a genetic modifier for risk and progression of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 100, 15041–15046.
  • Zhou, Q., Wu, Y., Nielsen, P. J., & Liu, Y. (1997). Homotypic interaction of the heat-stable antigen is not responsible for its co-stimulatory activity for T cell clonal expansion. European Journal of Immunology, 27, 2524–2528.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.